SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kabra Drugs - Quaterly Results

14 Aug 2025 Evaluate
The revenue for the June 2025 quarter is pegged at Rs. 71.50 millions against Rs. 0.00 millions recorded during the year-ago period.The Net Loss for the quarter ended June 2025 is Rs. -5.00 millions as compared to Net Loss of Rs. -5.46 millions of corresponding quarter ended June 2024 Operating profit Margin for the quarter ended June 2025 improved to -4.97% as compared to -5.46% of corresponding quarter ended June 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 71.50 0.00 0.00 71.50 0.00 0.00 0.00 0.00 0.00
Other Income 0.16 0.00 0.00 0.16 0.00 0.00 6.40 0.00 0.00
PBIDT -4.97 -5.46 -8.97 -4.97 -5.46 -8.97 -10.78 -7.36 46.47
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT -4.97 -5.46 -8.97 -4.97 -5.46 -8.97 -10.78 -7.36 46.47
Depreciation 0.03 0.00 0.00 0.03 0.00 0.00 0.07 0.00 0.00
PBT -5.00 -5.46 -8.42 -5.00 -5.46 -8.42 -10.85 -7.36 47.42
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00
PAT -5.00 -5.46 -8.42 -5.00 -5.46 -8.42 -10.86 -7.36 47.55
Equity 237.08 43.89 440.17 237.08 43.89 440.17 237.08 43.89 440.17
PBIDTM(%) -6.95 0.00 0.00 -6.95 0.00 0.00 0.00 0.00 0.00

Kabra Drugs Share Price

28.29 -0.25 (-0.88%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×